The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.
Joost C. M. Meijers
Joost C.M. Meijers
Department of Experimental Vascular Medicine
G1-143
Academic Medical Center
E-mail:
Name/email consistency: high
- Binding characteristics of thrombin-activatable fibrinolysis inhibitor to streptococcal surface collagen-like proteins A and B. Valls Serón, M., Plug, T., Marquart, J.A., Marx, P.F., Herwald, H., de Groot, P.G., Meijers, J.C. Thromb. Haemost. (2011)
- Protein C inhibitor (plasminogen activator inhibitor-3) and the risk of venous thrombosis. Meijers, J.C., Marquart, J.A., Bertina, R.M., Bouma, B.N., Rosendaal, F.R. Br. J. Haematol. (2002)
- High levels of coagulation factor XI as a risk factor for venous thrombosis. Meijers, J.C., Tekelenburg, W.L., Bouma, B.N., Bertina, R.M., Rosendaal, F.R. N. Engl. J. Med. (2000)
- Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives. Meijers, J.C., Middeldorp, S., Tekelenburg, W., van den Ende, A.E., Tans, G., Prins, M.H., Rosing, J., Büller, H.R., Bouma, B.N. Thromb. Haemost. (2000)
